SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Patrick Tang who wrote (122)7/17/1996 8:30:00 AM
From: eugenic1   of 849
 
2 pt. reversal rewards he who went bottom fishing.
I spoke to our PR man and am encouraged by a few items. New relationships
in Europe plan on selling kits vs. focusing efforts on medical equipment.
Old reps weren't getting the job done. Colorectal tests are in the works
and maybe we can get fda approval on a reasonable timeframe. I feel that
if the NMP-22 could be used as a screening test, not just monitoring
recurrence, the co. would get double+ its sales. PC-1 for prostate testing,
will be the big gun, the cancer list goes on and on. The NMP technology
will own this market, as it is twice as accurate in every catagory.
Maybe an upward trend in price will begin, this bloodbath should end
soon. Volatility will rule for a while. Timers and MM's will make sure
of that.
best returns
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News